{
    "nct_id": "NCT05285449",
    "official_title": "Influence of Cannabidiol on Glucose Tolerance and The Gut Microbiota",
    "inclusion_criteria": "* 18 years of age and older\n* Weight more than 110 pounds\n* Have a Body Mass Index greater than or equal to 25 kilograms/squared meters\n* Free of gastrointestinal or metabolic diseases\n* Sedentary (less than 150 minutes of moderate-intensity exercise per week during the previous 3 months)\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Less than 18 years of age\n* Pregnant or breastfeeding\n* Have known food allergies\n* Have been diagnosed with any autoimmune disorders or with compromised immune function\n* Celiac disease\n* Inflammatory bowel diseases\n* Gastrointestinal cancers\n* Diabetes\n* Human Immunodeficiency Virus\n* Adverse reaction to ingesting CBD oils, or CBD containing food products\n* Taking any of the following medications will be excluded as these may have negative interactions with CBD:\n* steroids,\n* 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors,\n* calcium channel blockers,\n* antihistamines,\n* human immunodeficiency virus antivirals\n* immune modulators,\n* benzodiazepines,\n* antiarrythmics,\n* antibiotics,\n* anesthetics,\n* antipsychotics,\n* antidepressants,\n* anti-epileptics,\n* beta blockers,\n* coumadin (warfarin),\n* proton pump inhibitors,\n* non-steroidal anti-inflammatory drugs,\n* angiotension II blockers,\n* oral hypoglycemic agents,\n* sulfonylureas.",
    "miscellaneous_criteria": ""
}